Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

748
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
748
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

859
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
859
Pleura of the Lungs01:13

Pleura of the Lungs

8.0K
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
8.0K
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

4.7K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
4.7K
Pneumothorax-II01:27

Pneumothorax-II

1.1K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
1.1K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The solitary pulmonary nodule in patients with previous cancer history: results of surgical treatment.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2013
Same author

Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma.

British journal of cancer·2013
Same author

Lung volume reduction surgery 10 years later.

The Journal of cardiovascular surgery·2012
Same author

Efficacy of fleece-bound sealing system (TachoSil®) in delayed anterior tracheal lacerations secondary to ischemic tracheal necrosis after total thyroidectomy.

Minerva chirurgica·2012
Same author

Lung volume reduction surgery 10 years later.

The Journal of cardiovascular surgery·2012
Same author

Two-stage treatment of a secondary aortoesophageal fistula after thoracic endovascular aneurysm repair.

The Journal of cardiovascular surgery·2012
Same journal

Unexpected evolution of COVID-19 in a heart transplant patient with multimorbidity recently submitted to thoracic surgery.

Minerva chirurgica·2020
Same journal

Ongoing clinical trials on axillary management.

Minerva chirurgica·2020
Same journal

Axillary management after neoadjuvant treatment.

Minerva chirurgica·2020
Same journal

Axillary observation alone versus sentinel node biopsy: past, present and future perspectives.

Minerva chirurgica·2020
Same journal

Patient flow for the management of ostomy patients.

Minerva chirurgica·2020
Same journal

The management of "fragile" and suspected COVID-19 surgical patients during pandemic: an Italian single-center experience.

Minerva chirurgica·2020
See all related articles

Related Experiment Video

Updated: Feb 20, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.3K

[Malignant pleural mesothelioma].

O Rena1, A Oliaro

  • 1Cattedra di Chirurgia Toracica, Università degli Studi, Turin, Italy.

Minerva Chirurgica
|November 27, 2001
PubMed
Summary
This summary is machine-generated.

Malignant pleural mesothelioma, linked to asbestos, has poor prognosis. Early epithelial subtype diagnosis and multimodality therapy show promise for improved survival.

More Related Videos

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.3K
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.7K

Related Experiment Videos

Last Updated: Feb 20, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.3K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.3K
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.7K

Area of Science:

  • Oncology
  • Environmental Medicine
  • Thoracic Surgery

Context:

  • Malignant pleural mesothelioma is a severe asbestos-related cancer with rising incidence.
  • Current treatments offer limited impact on survival, with a median prognosis of 9-17 months.
  • Diagnosis often relies on exclusion and thoracoscopic tissue sampling.

Purpose:

  • To review current understanding and treatment strategies for malignant pleural mesothelioma.
  • To highlight prognostic factors and therapeutic approaches based on disease stage and subtype.

Summary:

  • Epithelial subtype malignant pleural mesothelioma may have a better prognosis with early diagnosis and treatment.
  • Intrapleural immunotherapy or multimodality therapy are considered for early-stage disease.
  • Advanced stages (II-III) may benefit from a multimodality approach including surgery, radiotherapy, and chemotherapy, particularly for epithelial subtype with negative margins and lymph nodes.

Impact:

  • Identifies potential therapeutic benefits of multimodality treatment for specific patient groups.
  • Emphasizes the importance of early diagnosis and subtype in malignant pleural mesothelioma management.
  • Provides insights into current treatment limitations and future directions for this challenging cancer.